Skip to content

Clinical trials

Esophageal Neoplasms trials in Japan

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Esophageal Neoplasms Country / region: Japan Clear all

60 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20001
20033
20041
20051
20065
20074
20084
20091
20101
20141
20155
20161
20173
20192
20206
20215
20223
20232
20244
20255
20262

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed22
Recruiting14
Unknown status11
Active, not recruiting8
Terminated4
Enrolling by invitation1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Eli Lilly and Company5
Merck Sharp & Dohme LLC4
University of Yamanashi3
AstraZeneca2
Hamamatsu University2
Hokkaido Gastrointestinal Cancer Study Group2
Mie University2
Nagasaki University2
Novartis Pharmaceuticals2
Pfizer2

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Esophageal Neoplasms60
Stomach Neoplasms21
Carcinoma, Non-Small-Cell Lung14
Ovarian Neoplasms13
Colorectal Neoplasms10
Breast Neoplasms8
Endometrial Neoplasms8
Pancreatic Neoplasms8
Squamous Cell Carcinoma of Head and Neck8
Triple Negative Breast Neoplasms8

Trials

Showing 1 to 25 of 60. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.